Back to results
US 10,327,682 B2Granted
Method and apparatus for providing glycemic control
AssigneeAbbott Diabetes Care Inc.
InventorsMarc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
Life of this patent
Estimating the term…
Abstract
Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HbA1C levels are provided.
Claims22
A method implemented using one or more processors, comprising:
- obtaining, for a subject, a mean glucose value information, a glycemic risk weight, and a HbA1C level of the subject;
- determining, using the one or more processors, a rate of glycation of the subject based on a ratio of the mean glucose value information of the subject and the HbA1C level of the subject;
- determining, using the one or more processors, a target HbA1C level for the subject based at least in part on two or more subject-specific weights including at least the rate of glycation of the subject and the glycemic risk weight;
- providing, using the one or more processors, a therapy recommendation including a dosage for an insulin bolus on a display device operatively coupled to the one or more processors based at least in part on the determined target HbA1C level of the subject;
- and
- administering the insulin bolus to the subject using an infusion device according to the therapy recommendation.
3 more elements
An apparatus, comprising:
- a display device;
- one or more processors operatively coupled to the display device;
- and
- a memory for storing instructions which, when executed by the one or more processors, causes the one or more processors to:
- obtain, for a subject, a mean glucose value information, a glycemic risk weight, and a HbA1C level of the subject;
- determine a rate of glycation of the subject based on a ratio of the mean glucose value information of the subject and the HbA1C level of the subject;
- determine a target HbA1C level for the subject based at least in part on two or more subject-specific weights including at least the rate of glycation of the subject and the glycemic risk weight;
- provide a therapy recommendation including a dosage for an insulin bolus on the display device based at least in part on the determined target HbA1C level of the subject;
- and
- administer the insulin bolus to the subject using an infusion device according to the therapy recommendation.
7 more elements
Dependencies are inferred from the claim text.